🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Insight Molecular Diagnostics Inc.

IMDX Healthcare
$3.99 +$0.15 (3.91%)
Market Cap: $128.35 M
Gurus Holding
1
Popularity Rank
#4147
% of Shares Held
0.04%
Net Activity (Q4 2025)
-$76,500

Guru Ownership Trend

Guru Analysis for Insight Molecular Diagnostics Inc. (IMDX)

Insight Molecular Diagnostics Inc. (IMDX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $53,466.

Top institutional holders include Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $76,500 net outflow during the quarter.

On the selling side, Renaissance Technologies (RenTech) reduced exposure by 43.2%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$0
Total Buy Value
New Buys 0
Additions 0
-$76,500
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
1
Net Buyers
0

FAQs for Insight Molecular Diagnostics Inc. (IMDX)

Major holders include Renaissance Technologies (RenTech) ($100,500). According to the latest reported data, 1 tracked investment managers collectively hold approximately 13,400 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $76,500, with 0 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited IMDX. The total reported sell value was $76,500.

No tracked managers opened new positions or increased their holdings in IMDX during the most recent reporting period.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -43.2% 13,400 $100,500 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form